Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
Related Debate
Violence against healthcare providers: A disturbing trend in India
Violence against doctors and healthcare providers in India has been on the rise in recent years. Doctors, nurses and par...
Usability The top challenge in healthcare big data analytics
The Healthcare Analytics Market is expected to reach $18.7 billion by 2020 from $5.8 billion in 2015, sharesUdai Kumar...
NAC Favours Universal Health Coverage
The Sonia Gandhi-led National Advisory Council (NAC) accepted its Working Groups recommendations on universal health...
Merck files appeal against Delhi high court's interim order
US pharmaceutical major Merck Sharp and Dohme (MSD) has filed an appeal before the Delhi High Court challenging its sing...
Glivec developer Brian Druker hails SC ruling
Big Pharma found little support from the small guy on the street as the Indian Supreme Court's decision to reject pate...
Novartis loses Indian patent case
India's Supreme Court has rejected a plea by Novartis to patent an updated version of its cancer drug, Glivec. The Swis...
Patient resistance, ill-preparedness send most doc cessation attempts up in smoke
Despite intricate knowledge of the dangers of smoking tobacco, an online survey from the likes of the International ...
New online programme aims to curtail diabetes
Omada Health, a San Francisco based company, has launched its flagship online product, called Prevent, which is aimed ...
WHO cites TB threat
World Health Organization and Global Fund cite tuberculosis threat Urgent need for US$ 1.6 billion a year i...
Generic sales boost for Ranbaxy
The much awaited US approval for Ranbaxy Laboratories' generic version of anti-hypertension drug Diovan is likely to com...